Cabot Corp. CBT Stock Analysis

Cabot Corp. stock trades under the ticker CBT & has shown recent bullishness that traders & investors should take a closer look into.

CBT stock closed at $65.71/share on 7/7/2022.

Cabot Corp. CBT Stock’s Technical Performance Broken Down

Cabot Corp. CBT Stock's Technical Performance Over The Last Year

CBT Stock Price: $65.71

10 Day Moving Average: $64.08

50 Day Moving Average: $68.24

200 Day Moving Average: $62.00

RSI: 48.15

MACD: -1.618

Yesterday, CBT stock completed a bullish MACD crossover, gapping up 3.63% to settle above its 10 day moving average.

Their recent trading volumes have been about average compared to the year prior, and their RSI is neutral, signaling that there may be more bullish momentum in the near-term.

They will need to break above the $66.89 & $67.14/share resistance levels as they continue to climb higher.

Cabot Corp. CBT Stock As A Long-Term Investment

Long-term oriented investors will like CBT stock’s P/E (ttm) of 28.36, but may find their 3.98 P/B (mrq) to be a bit too rich.

They recently reported 29.7% Quarterly Revenue Growth Y-o-Y, with 42.7% Quarterly Earnings Growth Y-o-Y.

Their balance sheet will require a closer examination, with $215M of Total Cash (mrq) & $1.34B of Total Debt (mrq).

CBT stock pays a 2.27% dividend yield, which may not be stable in the long-run, with a 63.2% payout ratio.97.3% of CBT stock’s outstanding share float is owned by institutional investors.

Cabot Corp. CBT Stock As A Short-Term Trade Using Options

Short-term focused traders can use options to hedge against volatility, while profiting from movements in CBT stock’s price.

I am looking at the contracts with the 7/15 expiration date.

The $55, $65 & $50 call options are all in-the-money, listed from highest to lowest levels of open interest.

The $75, $70 & $80 puts are also all in-the-money, in order of most to least liquid.

Tying It All Together

CBT stock has many interesting attributes that traders & investors will find appealing.

Investors will like their recent growth & P/E (ttm), but will want to review their balance sheet to see how it may impact their dividend in the longer-run.

Traders will like their current momentum, but may be disappointed by how liquid their options are.

All-in-all, it is worth taking a closer look at CBT stock to see how it fits into your portfolio strategy.

*** I DO NOT OWN SHARES OF CBT STOCK AT THE TIME OF PUBLISHING THIS ARTICLE ***